Market Overview:
The global biocompatibility testing services market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth of this market is mainly attributed to the increasing demand for medical devices and cosmetics worldwide. In addition, the growing awareness about the importance of biocompatibility testing in ensuring product safety is also contributing to the growth of this market. The global biocompatibility testing services market can be segmented on the basis of type and application. On the basis of type, this market can be divided into in vitro and in vivo tests. The in vitro tests are further sub-segmented into cell culture assays, receptor binding assays, genotoxicity assays, cytotoxicity assays and other in vitro tests. The major application areas for biocompatibility testing are medical devices and cosmetics products. Geographically, this market can be segmented into North America, Latin America, Europe Asia Pacific and Middle East & Africa .
Product Definition:
Biocompatibility Testing Services are used to determine the safety of medical devices and pharmaceuticals when they come into contact with biological tissues. This testing is important in order to ensure that the device or drug does not cause any adverse reactions in the body.
In Vitro:
In Vitro (IV) is a Latin expression which means “in the glass”. It is a process of testing biologic materials and biological fluids for their compatibility with various systems or solutions. In vitro tests are used to determine the effect of solution components on living cells, tissues, and organisms in controlled conditions without affecting the end-users adversely.
In Vivo:
In vivo is Latin for living and refers to a biological process where an animal or human is used as a experimental model to study the effect of chemical compounds on cells, tissues, and organs. In vivo studies are often carried out to evaluate the toxic effects of chemicals on humans.
The most commonly used experimental animals in biomedical research include rats, mice, hamsters, dogs among others.
Application Insights:
The medical application segment dominated the global market in terms of revenue in 2017. The growth can be attributed to the increasing number of product approvals for various applications, such as implants and grafts, artificial ligaments and tendons, drug delivery systems, surgical tools & equipment, biologics production facilities & devices among others.
Cosmetics is expected to be one of the fastest-growing segments over the forecast period owing to rising demand for organic cosmetics products that are free from harmful chemicals. Moreover, growing awareness about personal care products with natural ingredients is likely to boost segment growth over the coming years.
North America was estimated as a dominant region in 2017 due its presence across major economies including U.S.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of biotechnology companies and research institutes involved in drug discovery and development. Moreover, increasing government funding for R&D activities pertaining to novel therapies is also expected to propel growth over the forecast period. Asia Pacific region is anticipated to witness lucrative growth during the forecast period owing to rising awareness regarding product testing services among potential customers as well as growing investments by market players for expansion of their business operations within this region.
Moreover, Latin America regional market offers tremendous potential due its emerging economy status coupled with flourishing pharmaceutical industry that caters high demand across Central & South American countries such as Brazil.
Growth Factors:
- Increasing demand for medical implants and devices
- Growing prevalence of chronic diseases
- Rising number of surgical procedures
- Technological advancements in biocompatibility testing services
- Growing awareness about biocompatibility testing services
Scope Of The Report
Report Attributes
Report Details
Report Title
Biocompatibility Testing Services Market Research Report
By Type
In Vitro, In Vivo
By Application
Medical, Cosmetics
By Companies
Wickham Laboratories, North American Science Associates, GLR Laboratories, Accuprec Research Labs, Nelson Laboratories, Toxikon, Pacific BioLabs, BioComp Laboratories, Morulaa HealthTech, Geneva Laboratories
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
236
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Biocompatibility Testing Services Market Report Segments:
The global Biocompatibility Testing Services market is segmented on the basis of:
Types
In Vitro, In Vivo
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Medical, Cosmetics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Wickham Laboratories
- North American Science Associates
- GLR Laboratories
- Accuprec Research Labs
- Nelson Laboratories
- Toxikon
- Pacific BioLabs
- BioComp Laboratories
- Morulaa HealthTech
- Geneva Laboratories
Highlights of The Biocompatibility Testing Services Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- In Vitro
- In Vivo
- By Application:
- Medical
- Cosmetics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Biocompatibility Testing Services Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Biocompatibility testing services are a type of laboratory test that is used to assess the potential for an object or material to cause adverse reactions in humans when it comes into contact with their body. This can be done by exposing the object or material to a variety of biological fluids and tissues, and then monitoring any changes that occur.
Some of the key players operating in the biocompatibility testing services market are Wickham Laboratories, North American Science Associates, GLR Laboratories, Accuprec Research Labs, Nelson Laboratories, Toxikon, Pacific BioLabs, BioComp Laboratories, Morulaa HealthTech, Geneva Laboratories.
The biocompatibility testing services market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Biocompatibility Testing Services Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Biocompatibility Testing Services Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Biocompatibility Testing Services Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Biocompatibility Testing Services Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Biocompatibility Testing Services Market Size & Forecast, 2020-2028
4.5.1 Biocompatibility Testing Services Market Size and Y-o-Y Growth
4.5.2 Biocompatibility Testing Services Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 In Vitro
5.2.2 In Vivo
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Medical
6.2.2 Cosmetics
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Biocompatibility Testing Services Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Biocompatibility Testing Services Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 In Vitro
9.6.2 In Vivo
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Medical
9.10.2 Cosmetics
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 In Vitro
10.6.2 In Vivo
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Medical
10.10.2 Cosmetics
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 In Vitro
11.6.2 In Vivo
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Medical
11.10.2 Cosmetics
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 In Vitro
12.6.2 In Vivo
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Medical
12.10.2 Cosmetics
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 In Vitro
13.6.2 In Vivo
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Medical
13.10.2 Cosmetics
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Biocompatibility Testing Services Market: Competitive Dashboard
14.2 Global Biocompatibility Testing Services Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Wickham Laboratories
14.3.2 North American Science Associates
14.3.3 GLR Laboratories
14.3.4 Accuprec Research Labs
14.3.5 Nelson Laboratories
14.3.6 Toxikon
14.3.7 Pacific BioLabs
14.3.8 BioComp Laboratories
14.3.9 Morulaa HealthTech
14.3.10 Geneva Laboratories
